Juan Sanchez | VP, Corporate Communications & IR |
Sharon Mates | Founder, Chairman, and CEO |
Mark Neumann | EVP & Chief Commercial Officer |
Lawrence J. Hineline | SVP, Finance and CFO |
Suresh Durgam | EVP & CMO |
Andrew Tsai | Jefferies |
Brian Abrahams | RBC Capital Markets |
Unidentified Analyst | J.P. Morgan Chase |
Michael DiFiore | Evercore ISI |
Marc Goodman | SVB Securities |
Ami Fadia | Needham & Company |
Charles Duncan | Cantor Fitzgerald |
Jason Gerberry | Bank of America |
David Amsellem | Piper Sandler & Co. |
Graig Suvannavejh | Mizuho Securities |
Ash Verma | UBS |
Unidentified Analyst | Goldman Sachs |
Thank you for standing by and welcome to the Intra-Cellular Therapies Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions].
As a reminder, today's program is being recorded.